Skip to main content

Novartis news and events in 2026

Novartis news, hiring, layoffs and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Dated updates
77
Last event
Nov 17, 2026
Open rolesSnapshot Nov 17, 2026
432

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

Overview

Novartis by topic

Latest events

Latest Novartis events

  1. In development
    New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)Novartis announced 52-week results from the Phase III RemIND program evaluating Rhapsido (remibrutinib) in chronic inducible urticaria.
  2. Recognition
    Novartis ranks first place in 2026 Access to Medicine IndexNovartis ranked first place in the 2026 Access to Medicine Index published by the Access to Medicine Foundation.
  3. Partnership ended
  4. In development
    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)Novartis initiated a second Phase 2 clinical study evaluating the VAV1-directed molecular glue degrader MRT-6160 (DDY391) in patients with active moderate to severe psoriatic arthritis.
  5. Revenue
  6. In development
    Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrenceNovartis announced positive six-year follow-up results from the Phase III NATALEE trial evaluating Kisqali plus endocrine therapy for stage II and III HR+/HER2- early breast cancer.
  7. Partnership
  8. Revenue
    3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
  9. In development
    Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
  10. News

Showing 10 of 25 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns every signal type for Novartis, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Novartis questions

What is the latest news on Novartis?
On Nov 12, 2026, globenewswire.com reported: New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU). This page tracks 25 news events for Novartis since Jul 20, 2026, each with a date and a source link.
What is going on with Novartis?
In the 90 days to Nov 19, 2026, Autobound tracked 20 news events, 3 hiring snapshots, 1 reported layoff round, 41 signals for Novartis. The newest story is from Nov 12, 2026 (In development), reported by globenewswire.com.
Is Novartis laying off employees?
bazonline.ch reported on Sep 2, 2026: Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned. Autobound lists 1 reported layoff round for Novartis. Each row states what its source reported, not a confirmed total.
What else does Autobound track for Novartis?
Beyond news and filings, Autobound lists 52+ signals for Novartis from 7 sources: Glassdoor (15+), Website changes (15+), Patents (10), Reddit (5), Web traffic (4), Employee growth (2), LinkedIn (1). See the Novartis signals page for the dated list.
Is Novartis hiring right now?
Yes. As of Nov 17, 2026, Novartis had 432 open roles, and Sales had the most with 27.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →